全文获取类型
收费全文 | 88310篇 |
免费 | 8658篇 |
国内免费 | 2768篇 |
专业分类
耳鼻咽喉 | 409篇 |
儿科学 | 2436篇 |
妇产科学 | 886篇 |
基础医学 | 7341篇 |
口腔科学 | 1118篇 |
临床医学 | 7963篇 |
内科学 | 8761篇 |
皮肤病学 | 1121篇 |
神经病学 | 6797篇 |
特种医学 | 1121篇 |
外国民族医学 | 7篇 |
外科学 | 2716篇 |
综合类 | 10617篇 |
现状与发展 | 10篇 |
一般理论 | 8篇 |
预防医学 | 8567篇 |
眼科学 | 1083篇 |
药学 | 30927篇 |
46篇 | |
中国医学 | 3809篇 |
肿瘤学 | 3993篇 |
出版年
2024年 | 183篇 |
2023年 | 1344篇 |
2022年 | 1803篇 |
2021年 | 3196篇 |
2020年 | 3257篇 |
2019年 | 3173篇 |
2018年 | 3088篇 |
2017年 | 3454篇 |
2016年 | 3367篇 |
2015年 | 3295篇 |
2014年 | 5508篇 |
2013年 | 8854篇 |
2012年 | 5559篇 |
2011年 | 5741篇 |
2010年 | 4739篇 |
2009年 | 4346篇 |
2008年 | 4171篇 |
2007年 | 4203篇 |
2006年 | 3711篇 |
2005年 | 3336篇 |
2004年 | 2880篇 |
2003年 | 2550篇 |
2002年 | 2014篇 |
2001年 | 1885篇 |
2000年 | 1529篇 |
1999年 | 1331篇 |
1998年 | 1247篇 |
1997年 | 1134篇 |
1996年 | 961篇 |
1995年 | 903篇 |
1994年 | 769篇 |
1993年 | 655篇 |
1992年 | 707篇 |
1991年 | 587篇 |
1990年 | 522篇 |
1989年 | 409篇 |
1988年 | 400篇 |
1987年 | 376篇 |
1986年 | 349篇 |
1985年 | 392篇 |
1984年 | 342篇 |
1983年 | 235篇 |
1982年 | 201篇 |
1981年 | 214篇 |
1980年 | 166篇 |
1979年 | 127篇 |
1978年 | 133篇 |
1977年 | 81篇 |
1976年 | 88篇 |
1975年 | 66篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
101.
皮质发育障碍模型的建立及其致痫敏感性的研究 总被引:1,自引:0,他引:1
目的:建立皮质发育障碍模型,探讨皮质发育障碍模型的敏感性。方法:在SD大鼠孕17d腹腔注入1,3-二氯乙烯-亚硝基脲(BCNU)制作皮质发育障碍模型;Nissl染色观察P60d仔鼠病理变化;选取P60d雄性仔鼠,腹腔注射氯化锂-毛果芸香碱,分别比较两组大鼠癫发生的潜伏期、持续状态时间和死亡率。结果:同龄仔鼠脑组织湿重实验组比对照组显著减轻(P<0.01);Nissl染色显示皮质变薄、皮质层次紊乱、海马区域异位细胞异常聚集;有皮质发育障碍的仔鼠注射氯化锂-毛果芸香碱后,癫发生的潜伏期显著缩短(P<0.01),癫持续状态时间延长(P<0.01),死亡率显著升高(P<0.05)。结论:BCNU致皮质发育障碍模型具有癫易感性。 相似文献
102.
AIM/BACKGROUND: Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease of unknown aetiology. Up to 10% of patients with typical features of PBC will have additional features of autoimmune hepatitis (AIH). A subset, however, have no such features but go on to develop a 'sequential' AIH overlap syndrome. Objectives: Describe our experience with eight patients who developed AIH after the diagnosis of PBC was made. METHODS: We reviewed the charts of all PBC patients over a 9-year period (from 1996 to 2005). Only PBC patients with no features of AIH were included. RESULTS: There were 1476 patients with PBC. Of these, eight patients developed features of AIH overlap syndrome based on biochemical and histological parameters. Treatment included prednisone and azathioprine for 24 or more months. The majority of patients remained on ursodeoxycholic acid (UDCA) throughout treatment. Response to therapy was defined by improvement in enzymes, and was rapid for all patients. One patient was able to discontinue treatment with prednisone and azathioprine, while seven have continued on therapy to date. CONCLUSIONS: A 'sequential' overlap syndrome of AIH with PBC can occur. Treatment with prednisone and azathioprine may lead to a rapid improvement in aminotransferase levels. 相似文献
103.
试论医学院校的转型和发展战略 总被引:2,自引:1,他引:1
我国医学院校的发展道路有通过“强强联合”并入综合性大学和通过学科多样化“转型”为多科性大学两种类型。“转型”方式虽然不受广泛的关注,却正在低调而广泛地运行,成为独立设置医学院校自我发展和提高的主要方式。转型期医学院校在发展战略上有明显共性,如专业学科布局的优化、大力扶植基础学科、整合临床资源凸显医学主体、校园规划和建设体现多科性大学的包容性等,应予以重视。 相似文献
104.
105.
盐酸戊乙奎醚用于全麻术前减少腺体分泌的研究 总被引:16,自引:1,他引:15
目的评价盐酸戊乙奎醚作为全麻术前用药减少腺体分泌的有效性与安全性。方法本研究采用多中心随机双盲平行对照观察。298例全麻病人随机分为三组,术前分别肌肉注射阿托品、盐酸戊乙奎醚或注射用水,测定注射后30min唾液分泌量。用视觉模拟评分(VAS)方法测定口干程度,记录不良反应。结果给药后30min,阿托品、盐酸戊乙奎醚和注射用水组唾液分泌量分别较给药前变化(-17·64±19·53)、(-22·30±21·04)和(2·71±19·46)mg。VAS阿托品、盐酸戊乙奎醚组用药后明显增加。给药后30min,阿托品、盐酸戊乙奎醚和注射用水组HR分别较给药前变化(1·65±8·82)、(-4·30±7·01)和(-0·54±6·49)次/分。观察期间无严重不良反应。结论盐酸戊乙奎醚作为全麻术前用药,可明显减少唾液分泌,无HR增快,无明显不良反应。 相似文献
106.
Theodore C. Bania MD MS Tom Ashar MD Gregory Press MD Patricia M. Carey MD 《Academic emergency medicine》2003,10(7):697-704
Long-term daily use of gamma-hydroxybutyrate (GHB) and related compounds has recently been associated with a withdrawal syndrome. To the best of the authors' knowledge, there are currently no animal models of GHB withdrawal. OBJECTIVES: The authors studied and described the effect of chronic dosing of GHB (3-6 days) on tolerance and withdrawal in a rat model. METHODS: Rats were administered GHB every three hours via intraperitoneal catheter. Groups of rats (2 per group) were dosed with GHB for either 3 (24 doses), 4 (32 doses), 5 (40 doses), or 6 (48 doses) days. The GHB dose was 0.25 g/kg for doses 1-8, 0.75 g/kg for doses 9-12, 1 g/kg for doses 13-16, 1.25 g/kg for doses 17-24, 1.5 g/kg for doses 25-32, 1.75 g/kg for doses 33-40, and 2 g/kg for doses 41-48. Following the last dose of GHB, the rats were scored using a 16-point ethanol intoxication-withdrawal scale rating spontaneous behaviors, response to handling, grooming, and neurological signs. Lower scores indicate intoxication, while higher scores indicate withdrawal. Scores were recorded at hours 0, 1, 2, 3, 4, 5, 6, 9, 12, and 24. RESULTS: Tolerance: Rats dosed with GHB for more days were less intoxicated one hour after their last GHB dose despite receiving higher doses. WITHDRAWAL: The scores for all rats dosed with GHB increased at hours 4 (p = 0.028), 5 (p = 0.037), 6 (p = 0.007), and 9 (p = 0.024) after the last dose, indicating withdrawal. The scores demonstrated a linear increase dependent upon the number of days of GHB dosing at hours 3 (p < 0.000), 4 (p = 0.004), 5 (p = 0.002), and 12 (p = 0.039) as well as prior to the last dose at hour 0 (p = 0.000). No rats developed seizures. CONCLUSIONS: Tolerance and mild withdrawal in rats can be induced by administering intraperitoneal GHB every three hours for 3-6 days. More prolonged dosing and higher doses of GHB may be necessary to induce severe withdrawal. 相似文献
107.
目的:自行开发中文语音检验系统,应用于血、尿液分析仪检测数据及患者姓名中文发音等事务管理.方法:采用Microsoft Access 2000建立相关数据库/表,在可视化编程语言Visual Basic 6.0环境中,通过标准串口通讯控件MsComm,接收仪器检测数据,调用Windows API中文语音函数,对患者姓名中文发音,并将编写的源代码生成单独可执行程序及其安装程序.结果:该程序应用于临床,检测了10万份样本,运行稳定,数据全部成功存储入库/表,中文语音清晰,使用简单快捷.结论:计算机与检验分析仪联机,可有效地对检测数据进行灵活的管理,同时清晰的中文发音,杜绝了报告单发放处的拥挤现象,为门诊检验提供一个井然有序的就医环境,亦有利于报告单规范化. 相似文献
108.
109.
110.
AKIKO TANAKA MASAHIRO MATSUMOTO YUJIRO HAYASHI KOJI TAKEUCHI 《Journal of gastroenterology and hepatology》2006,20(1):38-45
Background and Aim: We recently reported that cyclooxygenase (COX)-2 is upregulated in the rat small intestine after administration of indomethacin, and this may be the key to non-steroidal anti-inflammatory drug (NSAID)-induced intestinal damage. The present study investigated the mechanism for COX-2 expression induced in the rat small intestine by indomethacin, in relation with ulcerogenic processes.
Methods: Animals were given indomethacin or SC-560 p.o., and the intestinal mucosa was examined 24 h later.
Results: Indomethacin caused hemorrhagic lesions in the small intestine, accompanied with an increase in intestinal motility, bacterial invasion and inducible nitric oxide synthase (iNOS) activity, as well as the expression of COX-2 mRNA in the mucosa. Although SC-560 did not cause any damage, this agent caused intestinal hypermotility, the bacterial invasion and the upregulation of COX-2 expression. The mucosal PGE2 content was decreased by SC-560 at 3 h but recovered 12 h later, and this recovery of PGE2 was attenuated by both atropine and ampicillin, in addition to rofecoxib. The intestinal hypermotility response to indomethacin was prevented by both 16,16-dimethyl PGE2 and atropine, but not ampicillin. Yet all these agents inhibited not only the bacterial invasion but also the expression of COX-2 and iNOS activity in the intestinal mucosa following indomethacin treatment, resulting in the prevention of intestinal lesions.
Conclusion: These results suggest that COX-2 expression in the intestinal mucosa following the administration of indomethacin is associated with intestinal hypermotility and bacterial invasion. The intestinal hypermotility caused by COX-1 inhibition may be a key to COX-2 expression after administration of NSAIDs and their intestinal ulcerogenic properties. 相似文献
Methods: Animals were given indomethacin or SC-560 p.o., and the intestinal mucosa was examined 24 h later.
Results: Indomethacin caused hemorrhagic lesions in the small intestine, accompanied with an increase in intestinal motility, bacterial invasion and inducible nitric oxide synthase (iNOS) activity, as well as the expression of COX-2 mRNA in the mucosa. Although SC-560 did not cause any damage, this agent caused intestinal hypermotility, the bacterial invasion and the upregulation of COX-2 expression. The mucosal PGE
Conclusion: These results suggest that COX-2 expression in the intestinal mucosa following the administration of indomethacin is associated with intestinal hypermotility and bacterial invasion. The intestinal hypermotility caused by COX-1 inhibition may be a key to COX-2 expression after administration of NSAIDs and their intestinal ulcerogenic properties. 相似文献